Literature DB >> 32880746

Evolution of isolated systolic hypertension with normal central blood pressure in adolescents-prospective study.

Łukasz Obrycki1, Janusz Feber2, Grażyna Brzezińska3, Mieczysław Litwin4.   

Abstract

BACKGROUND: The clinical significance of isolated systolic hypertension with normal central blood pressure known as spurious hypertension (sHT) in adolescents and its evolution over time is not known.
METHODS: The aim of this study was to analyze changes in office, ambulatory blood pressure (ABPM), central systolic blood pressure (cSBP), hemodynamic parameters, and target organ damage (TOD) over a 1-year follow-up in a group of non-obese children with sHT.
RESULTS: Of 294 patients referred for primary hypertension, 138 patients (31 girls; 22%) had hypertension confirmed by ABPM. 48/138 (35%) patients (7 girls; 15%) were diagnosed with sHT (elevated office and ambulatory systolic BP, but normal cSBP); 43 of them (6 girls; 14%) were followed for 12 ± 3 months during non-pharmacological therapy. At baseline 7 (16%) patients had borderline values of cIMT or LVMi indicating mild TOD. After 12 months, 10/43 (3 girls; 23%) patients developed sustained HT (elevated office, ambulatory BP and cSBP), 11/43 (1 girl; 26%) maintained sHT, and 22/43 (2 girls; 51%) evolved to white coat hypertension or normotension. The cSBP values increased in 27 patients (4 girls; 63%), but the group average remained in the normal range. Prevalence of TOD did not change during observation. The multivariate regression analysis showed that the only predictor of cSBP change over time was a change in serum uric acid level.
CONCLUSIONS: In conclusion, after 1 year of non-pharmacological treatment, 23% of adolescents with sHT developed sustained hypertension, with the main predictor of cSBP change being the change in serum uric acid.

Entities:  

Keywords:  ABPM; Central systolic blood pressure; Children; Isolated systolic hypertension; Spurious hypertension; Uric acid

Mesh:

Substances:

Year:  2020        PMID: 32880746      PMCID: PMC7815547          DOI: 10.1007/s00467-020-04731-z

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  3 in total

1.  Isolated systolic hypertension of young-to-middle-age individuals implies a relatively low risk of developing hypertension needing treatment when central blood pressure is low.

Authors:  Francesca Saladini; Massimo Santonastaso; Lucio Mos; Elisabetta Benetti; Nello Zanatta; Giuseppe Maraglino; Paolo Palatini
Journal:  J Hypertens       Date:  2011-07       Impact factor: 4.844

2.  Leukocyte matrix metalloproteinase and tissue inhibitor gene expression patterns in children with primary hypertension.

Authors:  Joanna B Trojanek; Anna Niemirska; Jacek Michałkiewicz; Mieczysław Litwin; Renata Grzywa; Aldona Wierzbicka; Łukasz Obrycki; Zbigniew Kułaga; Mieczysław Szalecki
Journal:  J Hum Hypertens       Date:  2019-03-29       Impact factor: 3.012

3.  Hemodynamic Characterization of Primary Hypertension in Children and Adolescents.

Authors:  Ye Li; Haotian Gu; Manish D Sinha; Phil Chowienczyk
Journal:  J Am Heart Assoc       Date:  2020-06-06       Impact factor: 5.501

  3 in total
  1 in total

1.  Evaluation of Active Renin Concentration in A Cohort of Adolescents with Primary Hypertension.

Authors:  Anna Deja; Piotr Skrzypczyk; Magdalena Nowak; Małgorzata Wrońska; Michał Szyszka; Anna Ofiara; Justyna Lesiak-Kosmatka; Anna Stelmaszczyk-Emmel; Małgorzata Pańczyk-Tomaszewska
Journal:  Int J Environ Res Public Health       Date:  2022-05-13       Impact factor: 4.614

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.